Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

Share Price is delayed by 15 minutes
Get Live Data
1.24    0.00 (0.00%)
Bid:
1.20
Ask:
1.28
Spread: 0.08 (6.667%)
Market Cap: $21.21m
JPEL Live PriceLast checked at - London Stock Exchange

Intraday Jpel Priv Eqty Share Chart

Credit Facility

30 Apr 2012 09:00

RNS Number : 3248C
J.P. Morgan Private Equity Ltd
30 April 2012
 



 

 

 

JPEL ANNOUNCES in principle agreement for

EXTENSION OF $150 Million MULTI-CURRENCY CREDIT FACILITYWITH LLOYDS BANK CORPORATE MARKETS

 

* * *

 

GUERNSEY, 30 APRIL 2012

 

J.P. Morgan Private Equity Limited ("JPEL" or the "Company") is pleased to announce that it has agreed in principle to terms on a new multi-currency credit facility with a longer maturity date with Lloyds TSB Bank plc.

 

The new facility will expire in January 2017 and contains similar covenants to the Company's existing $150 million multi-currency facility which was due to expire in May 2013. Key terms of the proposed facility include:

 

·; LIBOR +280bps for a loan to value ratio (LTV) of less than or equal to 10%, with no LIBOR floor

·; LIBOR +330bps for a LTV ratio of greater than 10%, with no LIBOR floor

 

"We continue focus on the optimization of our capital structure." said Trevor Ash, JPEL's Chairman. "This proposed facility will provide JPEL with increased financial flexibility to support its strategic initiatives over the next several years."

 

"Moreover, extending the credit facility in 2017 will be an important milestone for JPEL. The Directors believe that the proposed refinancing will benefit the Company by allowing JPEL to focus on creating shareholder value while simultaneously representing the first step to clarifying the long-term capital structure" added Mr. Ash added.

 

The amended and extended credit facility is subject to final documentation and is currently expected to be completed in May. Furthermore, the Company anticipates that it will hold its annual general meeting on or about the end of June with materials available to shareholders on or about the end of May.

 

* * *

 

About J.P. Morgan Private Equity Limited

 

J.P. Morgan Private Equity Limited is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL, JPEZ, JPZZ) designed primarily to invest in the global private equity market. The investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market. On 17 August 2009, JPEL issued warrants free of subscription cost to shareholders on record. The warrants are publicly traded on the London Stock Exchange under the symbol "JPWW."

 

END

For further information please contact:

 

J.P. Morgan Private Equity Limited

Troy Duncan / Greg Getschow

+44 (0)20 7742 3032 / +1 212 648 1150

Troy.Duncan@jpmorgan.com / Gregory.Getschow@jpmorgan.com

 

Rosemary DeRise / Samantha Ladd

+1 212 648 2980 / +1 212 648 2982

Rosemary.DeRise@jpmorgan.com / Samantha.Ladd@jpmorgan.com

 

Peregrine Communications

Anthony Payne / Max Hilton

+44 203 178 6869

anthony.payne@peregrinecommunications.com / max.hilton@peregrinecommunications.com

 

For Lloyds Bank Corporate Markets

Louise Riordan

Financial Dynamics

+ 44 (0)20 7269 9308 / 07515 597 556

louise.riordan@fd.com

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBKKDQOBKKFQN
Date   Source Headline
9th Nov 20224:11 pmRNS2022 AGM CIRCULAR
27th Oct 20226:26 pmRNSNet Asset Value - September 2022
23rd Sep 20224:54 pmRNSAnnual Financial Report - 30 June 2022
13th Sep 20223:03 pmRNSNet Asset Value(s) - June 2022
13th Jul 202211:36 amRNSNet Asset Value(s) - May 2022
6th Jul 20224:26 pmRNSHolding(s) in Company
6th Jul 20227:00 amRNSUpdate to Shareholders
23rd Jun 20225:10 pmRNSNet Asset Value(s) - April 2022
17th May 20227:00 amRNSNet Asset Value(s) - March 2022
11th May 202211:27 amRNSNet Asset Value - February 2022
6th May 20227:00 amRNSNet Asset Value - January 2022
5th May 20225:39 pmRNSHolding(s) in Company
3rd May 20227:00 amRNSPortfolio Update
11th Apr 202212:34 pmRNSCompletion of Tenth Mandatory Redemption
4th Apr 20227:00 amRNSTenth Mandatory Redemption
17th Mar 20225:35 pmRNSHalf-year Report - 31 December 2021
7th Mar 20229:44 amRNSNet Asset Value - December 2021
19th Jan 20221:47 pmRNSNet Asset Value - November 2021
22nd Dec 20214:24 pmRNSNet Asset Value - October 2021
23rd Nov 20212:13 pmRNSAGM Results 2021
16th Nov 20214:42 pmRNSNet Asset Value - September 2021
3rd Nov 202112:29 pmRNSNet Asset Value - August 2021
2nd Nov 20211:49 pmRNS2021 AGM CIRCULAR
28th Oct 20217:00 amRNSHolding(s) in Company
26th Oct 20214:03 pmRNSHolding(s) in Company
25th Oct 20215:52 pmRNSNet Asset Value - July 2021
30th Sep 20218:27 amRNSAnnual Financial Report - 30 June 2021
12th Aug 20217:00 amRNSCompletion of Ninth Mandatory Redemption
5th Aug 20217:00 amRNSNinth Mandatory Redemption
4th Aug 20213:45 pmRNSNet Asset Value - June 2021
23rd Jul 20213:52 pmRNSLargest Investment Sale & 9th Mandatory Redemption
21st Jul 20213:16 pmRNSNet Asset Value - May 2021
3rd Jun 20213:59 pmRNSNet Asset Value - April 2021
14th May 20213:52 pmRNSNet Asset Value - March 2021
19th Apr 20219:34 amRNSNet Asset Value - February 2021
6th Apr 20217:00 amRNSHolding(s) in Company
1st Apr 20214:21 pmRNSHolding(s) in Company
31st Mar 20215:17 pmRNSNet Asset Value - January 2021
17th Mar 20215:13 pmRNSHalf-year Report - 31 December 2020
24th Feb 20214:35 pmRNSNet Asset Value - December 2020
28th Jan 20215:27 pmRNSHolding(s) in Company
25th Jan 20214:49 pmRNSHolding(s) in Company
15th Jan 20212:01 pmRNSNet Asset Value - November 2020
14th Jan 20213:30 pmRNSHolding(s) in Company
30th Dec 20207:00 amRNSCompletion of 8th Mandatory Redemption
17th Dec 20207:00 amRNSLargest Investment & 8th Mandatory Redemption
11th Dec 20203:01 pmRNSNet Asset Value - October 2020
26th Nov 202010:43 amRNSAGM Results 2020
26th Nov 202010:16 amRNSAGM Results 2020
20th Nov 20207:00 amRNSNet Asset Value - September 2020

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.